Threshold Pharmaceuticals Newswire

Comprehensive Real-Time News Feed for Threshold Pharmaceuticals.

Results 1 - 20 of 45 in Threshold Pharmaceuticals

  1. New Market Research Report: Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2014Read the original story

    Wednesday Apr 16 | SBWire

    ... AG, Astellas Pharma Inc., Astex Pharmaceuticals, Inc., Bayer AG, Ariad Pharmaceuticals, Inc., Threshold Pharmaceuticals, Inc., Synta Pharmaceuticals Corp., Chipscreen Biosciences Ltd, Ambit Biosciences Corporation, Deciphera Pharmaceuticals, LLC, ...

    Comment?

  2. 3 Stocks Near 52-Week Lows Worth BuyingRead the original story

    Tuesday Apr 15 | The Motley Fool

    ... Since then, however, its share price has vacillated without much direction. The promise of Threshold Pharmaceuticals lies with its lead drug TH-302. This unique therapy targets areas of tumor hypoxia , or areas of low oxygen. You see, normal ...

    Comment?

  3. Refractory Multiple Myeloma - Pipeline Review, H1 2014: New Research...Read the original story

    Friday Apr 11 | SBWire

    ... Biotech Inc., Pharmacyclics, Inc., Array BioPharma Inc., MorphoSys AG, Senesco Technologies, Inc., Threshold Pharmaceuticals, Inc., Synta Pharmaceuticals Corp., Acceleron Pharma, Inc., Altor BioScience Corporation, Stemline Therapeutics, Inc., ...

    Comment?

  4. Threshold Pharmaceuticals, Inc. Announces Results Of Two New...Read the original story

    Friday Apr 4 | BioSpace

    Threshold Pharmaceuticals, Inc. today announced that results of two new preclinical studies evaluating novel combinations of TH-302, its investigational hypoxia-targeted drug, with immunotherapy, antiangiogenic therapy, and radiotherapy for the potential treatment of cancer will be highlighted in poster presentations at the American Association for ... (more)

    Comment?

  5. Threshold Pharmaceuticals Announces Results of Two New Preclinical...Read the original story

    Thursday Apr 3 | Market Wire

    ... Darmstadt, Germany, which includes an option for Threshold to co-commercialize in the U.S. About Threshold Pharmaceuticals Threshold Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of drugs targeting tumor ...

    Comment?

  6. Biotechs Are Crashing: Here's This Week's Action PlanRead the original story w/Photo

    Monday Mar 31 | Investopedia

    ... below $5 again in the recent biotech rout. Biotech investors should also take a fresh look at Threshold Pharmaceuticals (Nasdaq: THLD ) , which has more than $80 million in cash on hand, a key drug that has shown solid clinical progress by starving ...

    Comment?

  7. Threshold Pharmaceuticals, Inc.' Partner Merck KGaA, Darmstadt,...Read the original story

    Thursday Mar 27 | BioSpace

    Threshold Pharmaceuticals, Inc. today announced that Threshold's partner Merck KGaA, Darmstadt, Germany, through its biopharmaceutical division, has initiated a Phase 1 dose escalation study assessing the safety, tolerability and anti-tumor activity of the investigational hypoxia-targeted drug TH-302 in combination with gemcitabine and ... (more)

    Comment?

  8. Threshold Pharmaceuticals' Partner Merck KGaA, Darmstadt,...Read the original story

    Thursday Mar 27 | Freshnews

    03/27/14 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Threshold's partner Merck KGaA, Darmstadt, Germany, through its biopharmaceutical division, has initiated a Phase 1 dose escalation study assessing the safety, ...

    Comment?

  9. Threshold Pharmaceuticals, Inc. Reports Fourth Quarter And Year End...Read the original story

    Mar 7, 2014 | BioSpace

    Threshold Pharmaceuticals, Inc. , today reported financial results for the fourth quarter and year ended December 31, 2013 and reported on clinical development objectives for TH-302, the Company's investigational hypoxia-targeted drug, which is currently being evaluated in two pivotal Phase 3 clinical trials, one in patients with advanced soft ... (more)

    Comment?

  10. Threshold Pharmaceuticals (THLD) Posts Quarterly Earnings, Misses Expectations By $0.03 EPSRead the original story

    Mar 6, 2014 | AmericanBankingNews.com

    Threshold Pharmaceuticals announced its earnings results on Thursday. The company reported EPS for the quarter, missing the Thomson Reuters consensus estimate of by $0.03, American Banking News reports.

    Comment?

  11. Threshold Pharmaceuticals Inc - 10-K - Management's Discussion and...Read the original story

    Mar 6, 2014 | Hispanic Business

    The following discussion and analysis should be read in conjunction with our consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K.

    Comment?

  12. Threshold Pharmaceuticals, Inc. Announces Presentations And Webcasts...Read the original story

    Feb 21, 2014 | BioSpace

    Threshold Pharmaceuticals, Inc. today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present a company overview at three upcoming investor conferences: 2014 RBC Capital Markets' Global Healthcare Conference, Wednesday, February 26, 2014, New York, NY, at 11:30 a.m. ET; Cowen and Company 34th Annual Health Care ... (more)

    Comment?

  13. Threshold Pharmaceuticals Announces Presentations and Webcasts at Three Upcoming Investor ConferencesRead the original story

    Feb 20, 2014 | Market Wire

    A replay of each presentation will be archived on the site for 30 days. About Threshold Pharmaceuticals Threshold Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of drugs targeting tumor hypoxia, the low oxygen condition found in the microenvironments of most solid tumors as well as the bone marrows of some ... (more)

    Comment?

  14. Just Released: "Threshold Pharmaceuticals, Inc. (THLD) -...Read the original story

    Feb 14, 2014 | PR-inside.com

    2014-02-14 18:20:34 - Fast Market Research recommends "Threshold Pharmaceuticals, Inc. (THLD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" from GlobalData, now available Threshold Pharmaceuticals, Inc. (Threshold) is a ...

    Comment?

  15. Micro Cap Stocks Under Bearish Claws - Delcath Systems, Inc....Read the original story

    Jan 28, 2014 | SBWire

    ... Today We bring special trend analysis of following stocks: Delcath Systems, Inc. ( NASDAQ:DCTH ), Threshold Pharmaceuticals, Inc.( NASDAQ:THLD ), Pacific Ethanol Inc ( NASDAQ:PEIX ), Zalicus Inc ( NASDAQ:ZLCS ) PLUS you'll get KingPennyStock's Pro ...

    Comment?

  16. Stocks to Track - AirMedia Group Inc (ADR) (NASDAQ:AMCN), Avalon Rare ...Read the original story

    Jan 23, 2014 | SBWire

    ... ), Avalon Rare Metals Inc (US listing) ( NYSEMKT:AVL ), Affymetrix, Inc ( NASDAQ:AFFX ), Threshold Pharmaceuticals, Inc ( NASDAQ:THLD ) AirMedia Group Inc (ADR) ( NASDAQ:AMCN ) showed a volume of 1.37 million shares by the end of last trade whereas ...

    Comment?

  17. Stocks in the Bullish Zone- NQ Mobile Inc (ADR) (NYSE:NQ), Trina...Read the original story

    Jan 23, 2014 | SBWire

    ... ), Trina Solar Limited (ADR) ( NYSE:TSL ), Gol Linhas Aereas Inteligentes SA (ADR) ( NYSE:GOL ), Threshold Pharmaceuticals, Inc. ( NASDAQ:THLD ). PLUS you'll get KingPennyStock's Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy NQ ...

    Comment?

  18. As M&A Season Heats Up, 3 Sectors To TargetRead the original story

    Jan 21, 2014 | Investopedia

    For much of the past five years, many companies have been squarely focused on their own operations, using excess cash to pay dividends, buy back stock, or reduce debt -- the three pillars of what we call Total Yield.

    Comment?

  19. Sizzling Gains- Infinity Pharmaceuticals Inc. (NASDAQ:INFI), AuRico...Read the original story

    Jan 21, 2014 | SBWire

    ... of following stocks: Infinity Pharmaceuticals Inc. ( NASDAQ:INFI ), AuRico Gold Inc ( NYSE:AUQ ), Threshold Pharmaceuticals, Inc. ( NASDAQ:THLD ), ZIOPHARM Oncology Inc. ( NASDAQ:ZIOP ). PLUS you'll get KingPennyStock's Pro Trading Rules Mini E-book ...

    Comment?

  20. Traders Alert - Glimcher Realty Trust (NYSE:GRT), Threshold...Read the original story

    Jan 21, 2014 | SBWire

    ... brings you the most vibrant coverage of following stocks: Glimcher Realty Trust ( NYSE:GRT ), Threshold Pharmaceuticals, Inc ( NASDAQ:THLD ), Maxwell Technologies Inc ( NASDAQ:MXWL ), Rentech, Inc ( NASDAQ:RTK ) Glimcher Realty Trust ( NYSE:GRT ) ...

    Comment?